Background. Health care programs for children with Down syndrome (DS) help improve the overall outcome and quality of life of these children. It is therefore very important to focus on the most common and serious problems of these patients, such as congenital heart defects and cardiac problems, and to keep medical guidelines updated with regard to these problems.
Down syndrome (DS, also known as trisomy 21) is the most common chromosomal abnormality, occurring in approx. 1 in 800 live births. Overexpression of the genes located on chromosome 21 is thought to underlie the pathogenesis of the neurologic, immunologic, endocrine and biochemical abnormalities that are characteristic of the syndrome. Children with DS often have congenital heart defects (CHD), gastrointestinal anomalies, immunologic disorders, and thyroid dysfunction. 1, 2 Approximately 44-58% of newborns with DS have CHD; atrioventricular septal defect (AVSD) and ventricular septal defect (VSD) are the most commonly encountered forms of CHD. 3, 4 Early recognition of CHD can lead to the optimal management of the defect. The survival of cases with DS has risen from 25 years to 49 years in the USA in a 14-year period, and congenital heart defects and respiratory infections are the most frequently reported causes of death in individuals with DS. 5 Although modern medical care has reduced the mortality rate to more acceptable values, it is still possible to further reduce both morbidity and mortality. Health care programs for children with DS help improve the overall outcome and quality of life of these children. It is therefore very important to focus on the most common and serious problems for these patients, such as congenital heart defects and cardiac problems, and to keep medical guidelines updated about these complications. 6 The aim of this study was to evaluate aortic intimamedia thickness (aIMT), lipid profiles and blood pressure in DS patients in comparison with a control group of ageand gender-matched neonates without DS.
Material and methods
Serum concentrations of lipids (total cholesterol -TC, LDL-cholesterol -LDL-C, HDL-cholesterol -HDL-C and triglyceride -TG), blood pressure, and abdominal aIMT were measured in patients with DS, and compared with those from a control group of age-and gendermatched neonates without DS. All the neonates with DS that were included in the study were born at or referred to the Department of Pediatrics at the Erciyes University, Faculty of Medicine (Kayseri, Turkey) between September 2009 and June 2011. All of them were full-term (≥38 gestational weeks). The control group was comprised of newborns who were referred to the well-baby clinic of the Erciyes University Medical Faculty hospital during the same period, and who had no cardiac pathology. The study was approved by the local Ethics Committee, and all the mothers provided written informed consent before enrollment.
Plasma lipid levels were measured in the venous blood of 20 infants with DS (13 males and 7 females) and 20 newborns without DS (also 13 males and 7 females). The blood samples obtained were immediately transferred into glass tubes, separated by centrifugation at 3500 rpm for 4 min, then kept at -80°C until analysis. Serum concentrations of TC, HDL-C, LDL-C and TG were measured by the photometric method adapted to an autoanalyzer (Architect ® C16000, Abbott Diagnostics, Lake Forest, USA). LDL-C was directly measured since not all the blood samples could be achieved during fasting.
Infant anthropometry was obtained by a trained research midwife. An infant electronic scale was used to obtain the subjects' weight in grams. The systolic, diastolic and mean blood pressure of the neonates was measured by the oscillometric technique, using a standardized protocol. The infants were studied at least 1.5 h after the last feeding. An appropriately sized cuff was placed on the right upper arm, and the baby was not touched for at least 15 min or until the subject attained a sleepy or quiet waking state. Three successive measurements were made at 2-min intervals, and the mean value of each measurement (systolic, diastolic and mean blood pressure) was recorded.
For the ultrasound imaging to evaluate aIMT, the subjects were laid quietly in a dark room. The abdominal aortic artery was scanned using a 1200×Plus high-resolution ultrasound mainframe with 2 linear array probes at 7.5 and 13 MHz (Shimadzu Corp., Kyoto, Japan). Abdominal IMT, defined as the distance between the leading edges of the media-adventitia interface and the blood-intima interface, was measured at a non-branched straight longitudinal part of the distal abdominal aorta, at least 1 cm long. The measurements were made with a manual measuring system. The dorsal arterial wall of the most distal abdominal aorta was chosen as the measurement site, since this area has been reported as the most lesion-prone. 7, 8 The abdominal aorta was identified in the lower abdomen with a 7.5-MHz linear array transducer, and the aortic intimamedia complex was assessed using a 13-MHz linear array transducer. The same experienced vascular sonographers, who were unaware of the clinical and laboratory situation of the newborns, performed all the ultrasonographic measurements.
All the statistical calculations were performed using SPSS software (v. 15.0, SPSS Inc., Chicago, USA). For continuous variables, the results are presented as the mean ±SD. Categorical variables are presented as frequency counts. The Shapiro-Wilk test was used to determine the normality of the distribution of the data. The χ 2 test was used to determine whether there was a statistically significant difference between the groups with respect to gender, delivery route and the presence or absence of consanguinity. The independent sample t-test was used to statistically compare demographic parameters (maternal and paternal age, age on admission, gestational age and birth weight), laboratory parameters (aIMT and lipid profiles) and blood pressure parameters between the 2 groups. A p-value < 0.05 was considered to be statistically significant for all the statistical tests.
Results
A comparison of the demographic characteristics of the study and control groups is shown in Table 1 . There were no statistically significant differences between the study and control groups with respect to gender, mode of delivery, consanguinity, maternal and paternal age, age of admission, gestational age or birth weight.
In the study group, there were 3 cases with ASD, 6 cases with VSD, 3 cases with AVSD, and 3 cases with PDA, whereas there were no cases of any cardiac pathology in the control group.
A comparison of the biochemical parameters, aIMT and blood pressure measurements is shown in Table 2 . There were no statistically significant differences between the 2 groups with respect to aIMT, plasma lipid levels or blood pressure measurements.
Discussion
New studies aimed at improving the management of the heart diseases most commonly affecting mortality and morbidity in patients with DS are needed. To the present authors' knowledge, there have been no studies investigating aIMT measurements in newborns and children with DS, and only 1 study of carotid intima-media thickness (IMT) in adult patients with DS. 9 In that study, Draheim et al. assessed the IMT in the left common carotid arteries of 52 adults with DS and in age-, gender-and race-matched adults without DS (mean age 42 ±5 years). Total body fat, blood pressure, fasting lipid profiles, insulin, glucose, C-reactive protein, homocysteine, physical activity and dietary intake were also evaluated. The adults with DS had lower IMT, lower systolic and diastolic blood pressure, and higher C-reactive protein, triglycerides and total body fat in comparison to the controls. Male gender and physical activity were reported as predictors of IMT for adults with DS; fasting insulin, fruit and vegetable intake, lowdensity lipoprotein cholesterol, age, smoking, and gender were predictors of IMT for the controls. The researchers concluded that adults with DS may be protected against atherosclerosis despite elevated total body fat and elevated cardiovascular disease risk factors. 9 The potential protective mechanisms against atherosclerosis in patients with DS are not clear and need to be investigated. Draheim There are very few studies of post-mortem examinations of DS patients in relation to atherosclerosis. Post-mortem examination of 5 institutionalized patients with DS (aged 40-66 years) showed no atheroma throughout their cardiovascular systems. The coronary arteries had no atheroma macroscopically, and microscopically showed only slight, diffuse intimal thickening that was normal for the subjects' age. In 2 cases a few fatty streaks were detected at the origin of the main aortic branches. 10 Moss et al. showed a normal prevalence of pre-atherosclerotic lesions in autopsy examinations of 7 non-institutionalized DS patients (10-25 years); atherosclerotic plaques were observed in 1 of these subjects (aged 14 years) but atheromatous aortic lesions were not seen in the 8 th subject (aged 50 years). 11 In a Finnish post-mortem study, Ylä-Herttuala et al. found a lower percentage of raised lesions and less calcium in the coronary arteries of 15 patients with DS (mean age: 51 years) compared with 6 intellectually disabled and 20 normal controls. Thus, even though the coronary arteries of DS patients were not completely free of atherosclerosis, it was milder than in other patients and free-living subjects of the same age. 12 Several variables may explain the decreased incidence of atherosclerosis in DS. Affected individuals are often institutionalized, and may be exposed to a diet low in animal fats; smoking is also less prevalent than in the general population. Furthermore, some studies have documented significantly lower values of arterial blood pressure than in inmates with other intellectual disabilities. 10, 13 Conflicting reports have been published on DS patients' lipid and lipoprotein concentrations, which are the best documented variables associated with the development of atherosclerosis. Most studies have compared subjects with DS with matched individuals admitted to the same institution for other disabling disorders or with unselected normal controls. Simon et al. found high serum cholesterol levels in young DS patients, whereas subsequent studies did not confirm this observation in groups of affected individuals whose ages ranged from early childhood to the early sixties. 10, [13] [14] [15] [16] [17] Triglyceride concentrations have been reported to be decreased, increased or unchanged in patients with trisomy 21 compared with matched controls. 10, 13, 16, 17 Therefore, in spite of the presence of some classical biochemical risk factors for atherosclerosis, its clinical manifestation is low in DS. The reasons for this remain unclear. In the present study, the plasma triglyceride and cholesterol levels of the patients with DS were not significantly different from those of the control group, and this finding was in accordance with most of the studies in this field.
The most important limitation of the present study was that the limited number of DS patients with a congenital heart disease precluded a comparison of aIMT among the subcategories of DS patients with respect to the type of congenital heart defect.
In the present study, aIMT -one of the most important indicators of atherosclerosis -was investigated in DS patients for the first time, but neither a significantly increased aIMT nor any significant changes in lipid profiles or blood pressure were detected in this group of patients. Whether aIMT differs according to the type of congenital heart defect (ASD, VSD, PDA, and AVSD) among DS patients remains to be determined in future studies.
